Clinical Trials Browser

Fibrosarcoma, Hyperinsulinism, Hypoglycemia, Insulinoma, Adenoma, Islet Cell, Liposarcoma, Neoplasms, Neuroectodermal Tumors, Primitive, Neuroendocrine Tumors

NCT05088798 2025-12-19

18FDOPA HI

Phase 2 Recruiting

100 enrolled

Endocrine

Hyperinsulinism, Hypoglycemia, Infant, Newborn, Diseases, Insulinoma, Glucose Metabolism Disorders

NCT02021604 2024-07-16

Fluorodopa F 18 in Congenital Hyperinsulinism and Insulinoma

Phase 1 Recruiting

250 enrolled

Endocrine

Hyperinsulinism, Hypoglycemia, Insulinoma, Congenital Hyperinsulinism

NCT04452396 2023-12-12

CGM (Continuous Glucose Monitoring) Use in Diagnosis of Spontaneous and Reactive Hypoglycaemia

Phase NA Terminated

7 enrolled

Endocrine

Hypoglycemia, Insulin Resistance, Insulinoma

NCT00001277 2022-06-07

Studies of Elevated Parathyroid Activity

Phase 2 Completed

1,553 enrolled 8 charts

EndocrineHead & Neck

Hypercalcemia, Hyperparathyroidism, Hypoglycemia, Multiple Endocrine Neoplasia, Parathyroid Neoplasms

NCT02779257 2022-03-04

Pasireotide Treatment for Neuroendocrine Tumor

Phase 4 Withdrawn

EndocrineGastrointestinalNET

Gastro-enteropancreatic neuroendocrine tumor, Hypoglycemia

NCT00005910 2008-03-04

Laparoscopy to Remove Pancreatic Tumors (Insulinomas)

Phase NA Completed

23 enrolled

Endocrine

Hypoglycemia, Insulin Resistance, Insulinoma, Adenoma, Islet Cell

Clinical Trials

Tumor HI

18FDOPA HI

Fluorodopa F 18 in Congenital Hyperinsulinism and Insulinoma

CGM (Continuous Glucose Monitoring) Use in Diagnosis of Spontaneous and Reactive Hypoglycaemia

Studies of Elevated Parathyroid Activity

Pasireotide Treatment for Neuroendocrine Tumor

Laparoscopy to Remove Pancreatic Tumors (Insulinomas)